4.5 Article

Genetic heterogeneity in HER2 testing may influence therapy eligibility

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Genome profiling of ERBB2-amplified breast cancers

Fabrice Sircoulomb et al.

BMC CANCER (2010)

Article Pathology

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification

Matteo Brunelli et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)

Article Oncology

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

Alfredo Santinelli et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Article Oncology

HER2 gene status in primary breast cancers and matched distant metastases

Coya Tapia et al.

BREAST CANCER RESEARCH (2007)

Article Cell Biology

Interphase FISH as a new tool in tumor pathology

M. G. Tibiletti

CYTOGENETIC AND GENOME RESEARCH (2007)

Article Medicine, General & Internal

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

Charles E. Geyer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

H Joensuu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Medicine, General & Internal

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

MJ Piccart-Gebhart et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

EH Romond et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)